ARCHIVES

Xeloda As Effective As 5-FU/LV, Five-Year Survival Data Show

This article is from The Cancer Letter archive.

Vol. 30 No. 9 | September 28, 2007

Download PDF Visit The Full Archive

Related Articles

ASCO proposes compromise to limit payment cuts proposed by Congress, CMS.

September 12, 2003

House Members Form Group To Address Cancer Policy.

February 23, 2001

NCI Cooperative Group, Cancer Center Trials Listed

October 26, 2007

Interferon Results Cool Expectations, But Other Reports At ASCO/AACR Demonstrate Solid Progress

June 6, 1980

In Brief: James Wallace Named CALGB Executive Officer; Gritz Receives First Joseph Cullen Award

September 11, 1992

Clinical Trials Approved By NCI CTEP Last Month

April 29, 2011